Trial · NCT05952882
Registered outcomes60
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 60
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Absolute Body Weight (BW) | 12 weeks of treatment | Treatment impact on change in body weight after 12 weeks of treatment. |
| Primary | Change in Percent Body Weight | 12 weeks of treatment | Treatment effect on reducing body weight expressed as percent body weight loss from baseline |
| Secondary | Body Mass Index (BMI) | 12 weeks of treatment | Treatment effect in reducing body mass |
| Secondary | Abdominal Adiposity (Waist Circumference [WC]) | 12 weeks of treatment | Treatment effect on loss of waist circumference (abdominal adiposity) with drug treatment |
| Secondary | Waist-to-Hip Ratio (WHR) | 12 weeks of treatment | Change in central adiposity with treatment as measured by waist-to-hip ratio. A reduction in ratio indicates a decrease in truncal fat. |
| Secondary | Waist-to Height Ratio [WHtR] | 12 weeks of treatment | Treatment effect on loss of central adiposity as determined by Waist-to Height Ratio. The lower the ratio indicates less abdominal adiposity. |
| Secondary | Total Fat Mass Evaluated by BIA | 12 weeks of treatment | Treatment effect on reduction of fat mass (kg) |
| Secondary | Total Body Fat (%) by BIA (Bioelectrical Impedance Analysis) machine | 12 weeks of treatment | Treatment effect on reduction of percent body fat by BIA |
| Secondary | Visceral Fat Level (VFL) | 12 weeks of treatment | Treatment effect on reduction of visceral fat level by BIA |
| Secondary | Total lean body mass | 12 weeks of treatment | Treatment impact on total lean body mass |
| Secondary | Glucose OGTT 0 min | 12 weeks of treatment | Treatment effect on fasting glucose prior to an oral glucose tolerance test (OGTT) |
| Secondary | Glucose OGTT 120 min | 12 weeks of treatment | Treatment effect on glucose measured at 120 minutes of an oral glucose tolerance test (OGTT) |
| Secondary | Insulin OGTT 0 min | 12 weeks of treatment | Treatment effect on fasting insulin prior to an oral glucose tolerance test (OGTT) |
| Secondary | Insulin OGTT 120 min | 12 weeks of treatment | Treatment effect on insulin measured at 120 minutes of an oral glucose tolerance test (OGTT) |
| Secondary | Fasting Insulin Sensitivity (HOMA-IR) | 12 weeks of treatment | Treatment effect on the HOMA-IR which is an insulin resistance measured derived from fasting blood glucose and insulin . The higher the number the more insulin resistant. |
| Secondary | Matsuda Insulin Sensitivity Index Derived From the OGTT (SI OGTT) | 12 weeks of treatment | The SI OGTT is a measure of peripheral insulin sensitivity derived from the insulin and glucoses measured during an OGTT. A increase in SI OGTTindicates greater insulin sensitivity |
| Secondary | Total Cholesterol Levels | 12 weeks of treatment | Treatment impact on improving total cholesterol levels |
| Secondary | High Density Lipoprotein Cholesterol (HDL-C) | 12 weeks of treatment | Impact of treatment on HDL levels after 12 weeks of treatment |
| Secondary | Triglyceride Levels (TRG) | 12 weeks of treatment | Drug effect of TRG levels after treatment |
| Secondary | Low Density Lipoprotein Cholesterol (LDL-C) | 12 weeks of treatment | Treatment impact on improving LDL-C after treatment |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05952882/registered